FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer

Not Applicable

Conditions: Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Interventions: Behavioral: Behavioral Intervention
Other: Survey Administration

First Posted Date: 2021-10-13

Last Posted Date: 2024-12-05

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 403

Registration Number: NCT05075759

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease

Phase 1

Recruiting

Conditions: Intestinal Graft Versus Host Disease

Interventions: Biological: Fecal Microbiota Transplantation
Procedure: Colonoscopy
Other: Survey Administration
Dietary Supplement: Nutritional Supplementation
Procedure: Biospecimen Collection

First Posted Date: 2021-10-05

Last Posted Date: 2025-05-16

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 72

Registration Number: NCT05067595

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions: Drug: Fludarabine
Drug: Clofarabine
Procedure: Hematopoietic Cell Transplantation
Radiation: Total-Body Irradiation
Drug: Treosulfan
Procedure: Echocardiography Test
Procedure: Multigated Acquisition Scan
Procedure: Lumbar Puncture
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Procedure: Biospecimen Collection

First Posted Date: 2021-08-06

Last Posted Date: 2025-05-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 80

Registration Number: NCT04994808

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya

Not Applicable

Completed

Conditions: HIV Prevention

Interventions: Behavioral: Formal peer PrEP referral + HIVST delivery

First Posted Date: 2021-07-29

Last Posted Date: 2025-03-03

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 504

Registration Number: NCT04982250

Locations: 🇰🇪
Partners in Health and Research Development, Thika, Kenya

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

Phase 2

Active, not recruiting

Conditions: Diamond-Blackfan Anemia
Hereditary Sideroblastic Anemia
Paroxysmal Nocturnal Hemoglobinuria
Shwachman-Diamond Syndrome
Hematologic Neoplasm With Germline GATA2 Mutation
Hematologic Neoplasm With Germline SAMD9 Mutation
Hematologic Neoplasm With Germline SAMD9L Mutation
Bone Marrow Failure Syndrome
Congenital Amegakaryocytic Thrombocytopenia

Interventions: Drug: Treosulfan
Drug: Fludarabine Phosphate
Drug: Tacrolimus
Drug: Methotrexate
Biological: Lapine T-Lymphocyte Immune Globulin
Procedure: Peripheral Blood Stem Cell Transplantation
Procedure: Allogeneic Bone Marrow Transplantation
Other: Quality-of-Life Assessment
Procedure: Echocardiography
Procedure: Multigated Acquisition Scan
Procedure: Bone Marrow Biopsy
Procedure: Bone Marrow Aspiration
Procedure: Biospecimen Collection
Procedure: X-Ray Imaging
Procedure: Computed Tomography

First Posted Date: 2021-07-16

Last Posted Date: 2025-02-10

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 40

Registration Number: NCT04965597

Locations: 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Rady Children's Hospital/UCSD, San Diego, California, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 21 locations

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Phase 2

Recruiting

Conditions: Recurrent Small Lymphocytic Lymphoma
Recurrent Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia
Refractory Small Lymphocytic Lymphoma

Interventions: Drug: Acalabrutinib
Drug: Venetoclax
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging

First Posted Date: 2021-06-28

Last Posted Date: 2024-11-19

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 20

Registration Number: NCT04941716

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study

Not Applicable

Completed

Conditions: Lung Carcinoma

Interventions: Other: Educational Intervention
Other: Questionnaire Administration

First Posted Date: 2021-06-11

Last Posted Date: 2022-07-21

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 25

Registration Number: NCT04922697

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Not Applicable

Completed

Conditions: Breast Carcinoma
Colon Carcinoma
Malignant Solid Neoplasm
Prostate Carcinoma
Ovarian Carcinoma
Pancreatic Carcinoma

Interventions: Other: Electronic Health Record Review
Other: Questionnaire Administration
Behavioral: Behavioral Intervention

First Posted Date: 2021-05-26

Last Posted Date: 2023-06-09

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 6

Registration Number: NCT04902144

Locations: 🇺🇸
Olympic Medical Cancer Center, Sequim, Washington, United States

NT-I7 for Kaposi Sarcoma in Patients With or Without HIV

Phase 1

Terminated

Conditions: AIDS-Related Kaposi Sarcoma
Kaposi Sarcoma
HIV Infection

Interventions: Biological: Efineptakin alfa

First Posted Date: 2021-05-19

Last Posted Date: 2024-06-27

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 8

Registration Number: NCT04893018

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States
🇺🇸
Harborview Medical Center, Seattle, Washington, United States

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Not Applicable

Recruiting

Conditions: Metastatic Malignant Solid Neoplasm
Locally Advanced Malignant Solid Neoplasm

Interventions: Other: Communication Intervention
Other: Best Practice
Other: Questionnaire Administration

First Posted Date: 2021-05-17

Last Posted Date: 2025-04-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 50

Registration Number: NCT04889144

Locations: 🇺🇸
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
Confluence Health, Wenatchee, Washington, United States

and more 1 locations

Home Terms & Conditions Privacy Policy